SOL SpA
SOL SpA is a chemicals company that operates in the commodity chemicals industry, producing and selling chemical products for industrial and consumer applications.
Business. SOL SpA (SOLS.MI) is an Italian company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana. As specific segment and geographic breakdowns are not provided, the company is described at the industry level as a participant in the commodity chemicals market.
Analyst recommendations
5 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
SOL SpA (SOLS.MI) is an Italian company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana. As specific segment and geographic breakdowns are not provided, the company is described at the industry level as a participant in the commodity chemicals market.
SOL SpA has a revenue of EUR 384.9 million, with 90.7 million shares outstanding, both basic and diluted, as of the latest financial data. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. This lack of liquidity data limits the ability to evaluate the company's short-term financial stability.
Profitability and return metrics are not available in the valuation snapshot, which means a direct comparison to industry_config preferred metrics and cohort medians cannot be made. Without these metrics, it is difficult to assess how SOL SpA's performance stacks up against its peers in the commodity chemicals industry.
The company's revenue is not segmented by geographic region or product line in the available data, so it is not possible to determine the extent of geographic or segment concentration. This lack of detail prevents an assessment of potential exposure to regional economic shifts or product-specific risks.
Growth trajectory is also unclear, as the outlook for the current and next fiscal years does not include numeric deltas or revenue history. Analysts have provided a mean price target of EUR 55.38, with a median of EUR 56.00, but these estimates do not include a detailed revenue growth forecast.
Risk factors include the inability to assess liquidity risk, which could affect the company's ability to meet short-term obligations. The dilution risk is currently low, and no adjustments have been applied to the valuation metrics. However, the absence of balance-sheet data means that potential dilution sources or credit risk factors cannot be evaluated.
Recent events or filings that could impact the company's operations or financial position are not detailed in the available data. The lack of recent transcripts or filings means that any strategic shifts or operational changes are not reflected in the current analysis.
- SOL SpA operates in the commodity chemicals industry with a revenue of EUR 384.9 million.
- The company's liquidity risk could not be assessed due to missing balance-sheet data.
- Analysts have provided a mean price target of EUR 55.38, but no detailed growth forecast is available.
- The company's profitability and return metrics are not available for comparison to industry benchmarks.
- No recent events or filings are detailed in the available data, limiting insight into strategic or operational changes.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €437.5M, +9,0% YoY.
- ▍Revenue €437.5M, +9,0% YoY
Revenue €433.9M, +12,7% YoY.
- ▍Revenue €433.9M, +12,7% YoY
Revenue €1.78B, +10,3% YoY; Operating income +13,9% YoY.
- ▍Revenue €1.78B, +10,3% YoY
- ▍Operating income +13,9% YoY
- ▍Net income +13,1% YoY
- ▍Free cash flow +56,8% YoY
- ▍Net margin 9.4%
Revenue €1.61B, +8,3% YoY; Operating income +4,3% YoY.
- ▍Revenue €1.61B, +8,3% YoY
- ▍Operating income +4,3% YoY
- ▍Net income +1,4% YoY
- ▍Free cash flow −60,0% YoY
- ▍Net margin 9.2%
Revenue €1.49B, +7,8% YoY; Operating income +17,9% YoY.
- ▍Revenue €1.49B, +7,8% YoY
- ▍Operating income +17,9% YoY
- ▍Net income +9,0% YoY
- ▍Free cash flow −27,3% YoY
- ▍Net margin 9.8%
Revenue €1.38B, +23,9% YoY; Operating income +41,8% YoY.
- ▍Revenue €1.38B, +23,9% YoY
- ▍Operating income +41,8% YoY
- ▍Net income +49,3% YoY
- ▍Free cash flow +73,5% YoY
- ▍Net margin 9.7%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 2,04 |
| Revenue | —no estimate | —no estimate | 1,9B EUR |
| Operating income | —no estimate | —no estimate | 291,7M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- SVP and CFO · Restricted Stock Units → Common StockDisposed 5 291exercise · 2026-07-30
- SVP, Ref. and App. Solutions · Restricted Stock Units → Common StockDisposed 3 176exercise · 2026-07-30
- SVP, Gen. Counsel and Corp Sec · Restricted Stock Units → Common StockDisposed 4 234exercise · 2026-07-30
- SVP, Gen. Counsel and Corp Sec · Restricted Stock Units → Common StockDisposed 2 304exercise · 2026-07-28
- SVP, Ref. and App. Solutions · Restricted Stock Units → Common StockDisposed 2 318exercise · 2026-07-28
- SVP and CFO · Restricted Stock Units → Common StockDisposed 3 142exercise · 2026-07-28
- Chief Accounting Officer · Restricted Stock Units → Common StockDisposed 8 600exercise · 2026-06-16
- SVP, Gen. Counsel and Corp Sec · Restricted Stock Units → Common StockAcquired 4grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- SVP, Gen. Counsel and Corp Sec · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- SVP, Gen. Counsel and Corp Sec · Restricted Stock Units → Common StockAcquired 5grant · 2026-06-10
- SVP, Gen. Counsel and Corp Sec · Restricted Stock Units → Common StockAcquired 19grant · 2026-06-10
- Director · Restricted Stock Units → Common StockAcquired 2grant · 2026-06-10
- SVP, Ref. and App. Solutions · Restricted Stock Units → Common StockAcquired 5grant · 2026-06-10
- SVP, Gen. Counsel and Corp Sec · Restricted Stock Units → Common StockAcquired 6grant · 2026-06-10
- SVP and CFO · Restricted Stock Units → Common StockAcquired 28grant · 2026-06-10
- SVP and CFO · Restricted Stock Units → Common StockAcquired 5grant · 2026-06-10
- SVP and CFO · Restricted Stock Units → Common StockAcquired 3grant · 2026-06-10
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- SOL SpA Market data — financials · 2026-05-29
- SOL SpA Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,06 %$104M
- Investment Managers · as of 2026-03-310,04 %$203M
- Investment Managers · as of 2026-03-310,03 %$54M
- Investment Managers · as of 2026-03-310,03 %$138M
- Investment Managers · as of 2026-03-310,03 %$202M
- Investment Managers · as of 2026-03-310,02 %$53M
- Brokerage Firms · as of 2026-03-310,02 %$74M
- Investment Managers · as of 2026-03-310,02 %$0M
- Institutional Investor · as of 2026-03-310,02 %$39M
- Investment Managers · as of 2026-03-310,02 %$120M
- Institutional Investor · as of 2026-03-310,02 %$83M
- Investment Managers · as of 2026-03-310,01 %$29M
- Investment Managers · as of 2026-03-310,01 %$109M
- Investment Managers · as of 2026-03-310,01 %$27M
- Investment Managers · as of 2026-03-310,01 %$20M
- Investment Managers · as of 2026-03-310,01 %$379M
- Investment Managers · as of 2025-12-310,01 %$893M
- Investment Managers · as of 2026-03-310,01 %$195M
- Investment Managers · as of 2026-03-310,01 %$184M
- Institutional Investor · as of 2026-03-310,01 %$45M
- Institutional Investor · as of 2026-03-310,01 %$191M
- Brokerage Firms · as of 2026-03-310,01 %$49M
- Investment Managers · as of 2026-03-310,01 %$23M
- Investment Managers · as of 2026-03-310,01 %$11M
- Funds · as of 2026-03-310,01 %$40M
- Investment Managers · as of 2026-03-310,00 %$16M
- Investment Managers · as of 2026-03-310,00 %$13M
- Institutional Investor · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- SVP, Gen. Counsel and Corp Sec · Common StockOther 4 234 · 2026-07-30
- SVP, Ref. and App. Solutions · Common StockOther 3 176 · 2026-07-30
- SVP, Ref. and App. Solutions · Common StockOther 1 592 @ $58,65$93K · 2026-07-30
- SVP, Gen. Counsel and Corp Sec · Common StockOther 2 122 @ $58,65$124K · 2026-07-30
- SVP and CFO · Common StockOther 5 291 · 2026-07-30
- SVP and CFO · Common StockOther 2 651 @ $58,65$155K · 2026-07-30
- SVP, Ref. and App. Solutions · Common StockOther 1 156 @ $58,29$67K · 2026-07-28
- SVP, Ref. and App. Solutions · Common StockOther 2 317 · 2026-07-28
- SVP and CFO · Common StockOther 1 575 @ $58,29$92K · 2026-07-28
- SVP and CFO · Common StockOther 3 142 · 2026-07-28
- SVP, Gen. Counsel and Corp Sec · Common StockOther 1 155 @ $58,29$67K · 2026-07-28
- SVP, Gen. Counsel and Corp Sec · Common StockOther 2 304 · 2026-07-28
- Chief Accounting Officer · Common StockOther 8 599 · 2026-06-16
- Chief Accounting Officer · Common StockOther 3 244 @ $85,79$278K · 2026-06-16
- SVP and Chief HR Officer · Common StockOther 5 464 @ $86,69$474K · 2026-06-02
- SVP and Chief HR Officer · Common StockOther 11 583 · 2026-06-02
- Director · Common StockOther 1 785 · 2026-05-22
- Director · Common StockOther 1 785 · 2026-05-22
- Director · Common StockOther 1 785 · 2026-05-22
- Director · Common StockOther 1 785 · 2026-05-22
- Director · Common StockOther 1 785 · 2026-05-22
- Director · Common StockOther 1 785 · 2026-05-22
- Director · Common StockOther 1 785 · 2026-05-22
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -60.2%Derived (calculated)
- Net margin (FY 2025-12-31): 6.1%Derived (calculated)
- Return on equity (FY 2025-12-31): 16.8%Derived (calculated)
- Return on assets (FY 2025-12-31): 4.2%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.39xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 3.04xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 13.5%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 7.0%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -60.2%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -60.1%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -46.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 16.9%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 3.1%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -19.2%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -56.7%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 13.4%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 135.8%Derived (calculated)
- Net income (annual): USD 237MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 1SEC XBRL filing
- Revenue (annual): USD 3.89BSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 1SEC XBRL filing
- Cost of revenue (annual): USD 2.64BSEC XBRL filing
- Cash & equivalents (annual): USD 534MSEC XBRL filing
- Current liabilities (annual): USD 1.71BSEC XBRL filing